Literature DB >> 942386

Inactivation of cathepsin D by dithiophosgene and by 2,2-dichloro-1,3-dithiacyclobutanone.

E T Rakitzis, T B Malliopoulou.   

Abstract

Cathepsin D, purified from bovine spleen, is inactivated by the unstable inhibitors dithiophosgene and 2,2-dichloro-1,3-dithiacyclobutanone. Inhibition constants are identical for both of the compounds tested: Ki 96.1 muM;k/c0.406. It appears that the active species is 2,2-dichloro-1,3-dithiacyclobutanone, to which dithiophosgene is hydrolysed before cathepsin D inactivation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 942386      PMCID: PMC1172645          DOI: 10.1042/bj1530737

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  3 in total

1.  Fundamental mechanisms of alkylation.

Authors:  C C PRICE
Journal:  Ann N Y Acad Sci       Date:  1958-04-24       Impact factor: 5.691

2.  Cathepsin D: rapid isolation by affinity chromatography on haemoglobin-agarose resin.

Authors:  R Smith; V Turk
Journal:  Eur J Biochem       Date:  1974-10-01

3.  Kinetics of irreversible enzyme inhibition by an unstable inhibitor.

Authors:  E T Rakitzis
Journal:  Biochem J       Date:  1974-08       Impact factor: 3.857

  3 in total
  4 in total

1.  Kinetics of protein modification, and/or enzyme inactivation, reactions by an unstable modifying agent.

Authors:  E T Rakitzis
Journal:  Biochem J       Date:  1987-09-15       Impact factor: 3.857

2.  Kinetics of irreversible enzyme inhibition by an unstable inhibitor.

Authors:  E T Rakitzis
Journal:  Biochem J       Date:  1981-11-01       Impact factor: 3.857

3.  Activation of cathepsin D by glycine ethyl ester.

Authors:  A Dionyssiou-Asteriou; E T Rakitzis
Journal:  Biochem J       Date:  1979-01-01       Impact factor: 3.857

Review 4.  Cathepsin D-Managing the Delicate Balance.

Authors:  Olja Mijanovic; Anastasiia I Petushkova; Ana Brankovic; Boris Turk; Anna B Solovieva; Angelina I Nikitkina; Sergey Bolevich; Peter S Timashev; Alessandro Parodi; Andrey A Zamyatnin
Journal:  Pharmaceutics       Date:  2021-06-05       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.